PRTN3 and autoimmune disease: In autoimmune disorders such as SLE, ANCA-associated vasculitis, RA, Gout, and psoriasis, defective NETs clearance and exposure of autoantigens like citrullinated histones, MPO, and PR3 contribute directly to loss of immune tolerance and sustained inflammation [63].